Skip to main content
SpringerLink
Log in

Metabolic bone disease in IBD

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

A substantial number of patients with inflammatory bowel disease (IBD) will manifest extra-intestinal complications. Metabolic bone disease and arthropathies are among the most debilitating of these. Decreased bone mineral density and increased fracture risk may occur in relation to the underlying disease itself or result from vitamin, mineral, and hormonal deficiencies; medications used to treat the underlying disease; lifestyle; and perhaps other factors. In many cases, the factors remain unidentified. Options for the treating clinician include correction of these deficiencies, treatment of the underlying disease, and use of medication to promote bone formation and decrease bone resorption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Dresner-Pollak R, Karmeil F, Eliakim R, et al.: Increased urinary n-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000, 95:699–704. This study showed that a urinary biochemical marker of bone resorption may have clinical utility in IBD patients for the prediction of decreased spinal bone mineral density (BMD).

    Article  PubMed  CAS  Google Scholar 

  2. Ott SM: Metabolic bone disease. In Primer on the Rheumatic Diseases. Edited by Schumacher HR. Atlanta: Arthritis Foundation; 1993:290–293.

    Google Scholar 

  3. Silverberg MS, Steinhart AH: Bone density in inflammatory bowel disease. Clin Perspect Gastroenterol 2000, 3:117–124.

    Google Scholar 

  4. Clements D, Motley RJ, Evans WD, et al.: Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Pharmacol 1992, 27:1055–1060. Both patients with Crohn's disease and those with ulcerative colitis exhibit progressive cortical bone loss over time, suggesting a need to monitor BMD, according to this report.

    CAS  Google Scholar 

  5. Kirchner BS, DeFavaro M, Jensen W: Lactose malabsorption in children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1969, 56:751–757.

    Google Scholar 

  6. Adachi J, Rostom A: Metabolic bone disease in adults with inflammatory bowel disease. Inflamm Bowel Dis 1999, 3:200–211.

    Google Scholar 

  7. Sheikh MS, Schiller LR, Fordtran JS: In vivo intestinal absorption of calcium in humans. Miner Electrolyte Metab 1990, 78:1195.

    Google Scholar 

  8. Sheikh MS, Ramirez A, Emmett M, et al.: Role of vitamin D-dependent and vitamin D-independent mechanism in absorption of food calcium. J Clin Invest 1988, 81:126–132.

    PubMed  CAS  Google Scholar 

  9. Hylander E, Ladefoged K, Jarnum S: The importance of the colon in calcium absorption following small-intestinal resection. Scand J Gastroenterol 1980, 15:55–60.

    PubMed  CAS  Google Scholar 

  10. Dawson-Hughes B, Stern DT, Shipp CC, Rasmussen HM: Effect of lowering calcium intake in fractional whole body calcium retention. J Clin Endocrinol Metab 1988, 67:62–68.

    Article  PubMed  CAS  Google Scholar 

  11. Ireland P, Fortran JS: Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 1973, 52:2672–2681.

    PubMed  CAS  Google Scholar 

  12. Compston JE, Ayers AB, Horton LWL, Tighe JR: Osteomalacia after small-intestinal resection. Lancet 1978, 1:9–12.

    Article  PubMed  CAS  Google Scholar 

  13. Nunan TO, Compston JE, Tonge C: Intestinal calcium absorption in patients after jejuno-ileal bypass or small intestinal resection and the effect of vitamin D. Digestion 1986, 34:9–14.

    Article  PubMed  CAS  Google Scholar 

  14. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH: Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982, 83:1252–1258.

    PubMed  Google Scholar 

  15. Bar-Shavit Z, Teitelbaum SL, Reitsman P, et al.: Induction of monocyte differentiation and bone resorption by 1, 25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 1983, 80:5907–5910.

    Article  PubMed  CAS  Google Scholar 

  16. Holick MF: Vitamin D. In Modern Nutrition in Health and Disease. Edited by Shils ME, Olson JA, Shike M. Philadelphia: Lea and Febiger; 1994:319.

    Google Scholar 

  17. Davies M, Mawr EB, Krawitt EL: Comparative absorption of vitamin D3 and 25-hydroxy vitamin D3 in intestinal disease. Gut 1980, 21:287–292.

    PubMed  CAS  Google Scholar 

  18. Basha B, Rao S, et al.: Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med 2000, 108:296–300. Report from a study showing that asymptomatic osteomalacia is often unsuspected or undiagnosed until the patient presents with bone fractures.

    Article  PubMed  CAS  Google Scholar 

  19. Conly JM, Stein K, Worobetz L, Rutledge-Harding S: The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994, 89:915–923.

    PubMed  CAS  Google Scholar 

  20. Knappen MHJ, Hamulyak K, Vermeer C: The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 1989, 111:1001–1005.

    Google Scholar 

  21. Chawla A, Iofel E: Vitamin K status and bone mineral density in children with Crohn's disease [abstract]. Gastroenterology 2000, 118:A63.

    Google Scholar 

  22. Ghosh S, Cowen S, Hannan WJ, Ferguson A: Low bone mineral density in Crohn's disease, but not ulcerative colitis at diagnosis. Gastroenterology 1994, 107:1031–1039. This study showed that bone density was decreased at diagnosis and prior to medical treatment in patients with Crohn's disease and normal vitamin D status. This suggests that underlying IBD and systemic inflammatory response may affect bone density, although these findings were not observed in newly diagnosed ulcerative colitis.

    PubMed  CAS  Google Scholar 

  23. Bertolini DR, Nedwin GE, Bringman TS, et al.: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 1986, 319:516–518.

    Article  PubMed  CAS  Google Scholar 

  24. Konig A, Muhlbauer RC, Fleisch H: Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice. J Bone Min Res 1988, 3:621–627.

    CAS  Google Scholar 

  25. Gowen M, Wood DD, Ihrie EJ, et al.: Interleukin 1-like factor stimulates bone resorption in vitro. Nature 1983, 306:378–380.

    Article  PubMed  CAS  Google Scholar 

  26. Nguyen L, Dewhirst FE, Hausahka PV, Stashenko P: Interleukin-1B stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytol Res 1991, 10:15–21.

    CAS  Google Scholar 

  27. Ishimi Y, Miyaura C, Jin CH, et al.: IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990, 145:3297–3303.

    PubMed  CAS  Google Scholar 

  28. Lo Casio V, Bonucci E, Imbimbo B, et al.: Bone loss in response to long-term glucocorticoid therapy. Bone 1990, 8:39–51.

    Article  Google Scholar 

  29. Lukert B, Kream BE: Clinical and basic aspects of glucocorticoid action in bone. In Principles of Bone Biology. Edited by Bilezikian JP, Raisz LG, Rodan GA. New York: Academic Press; 1996:533–548.

    Google Scholar 

  30. Cino M, Greenberg GR: Bone mineral density in Crohn's disease patients receiving long-term budesonide [abstract]. Gastroenterology 1998, 114:A952.

    Article  Google Scholar 

  31. D'Haens G, Verstraete A, Cheyns K, et al.: Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease. Aliment Pharmacol Ther 1998, 12:419–424.

    Article  PubMed  Google Scholar 

  32. Stanislavjevic S, Babcock A: Fractures in children treated with methotrexate for leukemia. Clin Orthop 1977, 125:139–144.

    Google Scholar 

  33. Silvennoinen A, Lehtola JK, Niemela SE: Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996, 31:367–371.

    PubMed  CAS  Google Scholar 

  34. Robinson RJ, Krzywicki T, Almond L, et al.: Effect of low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998, 115:36–41.

    Article  PubMed  CAS  Google Scholar 

  35. Takeuchi M, Kakushi H, Tohkin M: Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun 1994, 204:905–911.

    Article  PubMed  CAS  Google Scholar 

  36. Robinson RJ, Iqbal SJ, Al-Azzawi F, et al.: Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther 1998,12:21–25.

    Article  PubMed  CAS  Google Scholar 

  37. Gravallese EM, Kantrowitz FG: Arthritis manifestations of inflammatory bowel disease. Am J Gastroenterol 1988, 83:703–709.

    PubMed  CAS  Google Scholar 

  38. Buchman AL: Bones and Crohn's: problems and solutions. Inflamm Bowel Dis 1999, 3:212–227.

    Google Scholar 

  39. Geijer M, Sihlbom H, Gothlin JH, Nordborg E: The role of CT in the diagnosis of sacro-ileitis. Acta Radiol 1998, 39:265–268.

    Article  PubMed  CAS  Google Scholar 

  40. Salmi M, Rajala P, Jalkanen S: Homing of mucosal lymphocytes to joints: distinct endothelial ligands in synovium mediate lymphocyte subtype specific adhesion. J Clin Invest 1997 99:2165–2172.

    Article  PubMed  CAS  Google Scholar 

  41. Martinez-Lavin M: Hypertrophic osteoarthropathy. In Primer of the Rheumatic Diseases. Edited by Schumacher HR. Atlanta: Arthritis Foundation; 1993:262–263.

    Google Scholar 

  42. Freeman HJ, Kwan WCP: Brief report: non-corticosteroidassociated osteonecrosis of the femoral head in two patients with inflammatory bowel disease. N Engl J Med 1993, 329:1314–1316.

    Article  PubMed  CAS  Google Scholar 

  43. Iqbal MM: Osteoporosis: epidemiology, diagnosis and treatment. South Med J 2000, 93:2–18.

    PubMed  CAS  Google Scholar 

  44. Consensus Development Conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1994, 94:646–650.

  45. World Health Organization: Assessment of Fractures Risk and Its Application to Screening for Postmenopausal Osteoporosis, Technical Reports Series Number 843. Geneva: World Health Organization; 1994.

    Google Scholar 

  46. Haderslev KV, Tjellesen L, Sorensen HA, Staun M: Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease: a double blind controlled study [abstract]. Gastroenterology 2000, 118:A117.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Hepatology and Nutrition, University of Texas-Houston Medical School, Houston, TX, USA

    Ivelisse Lopez MD

  2. Division of Gastroenterology and Hepatology, Northwestern University Medical School, 676 North St. Clair Street, Suite 880, 60611, Chicago, IL, USA

    Alan L. Buchman MD, MSPH

Authors
  1. Ivelisse Lopez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan L. Buchman MD, MSPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lopez, I., Buchman, A.L. Metabolic bone disease in IBD. Curr Gastroenterol Rep 2, 317–322 (2000). https://doi.org/10.1007/s11894-000-0025-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-000-0025-9

Keywords

Search

Navigation